Ep. 145: “The Genetics of Innate Inflammation” Featuring Dr. Seth Masters
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
Dr. Seth Masters is the Head of the Centre for Innate Immunity and Infectious Diseases at the Hudson Institute of Medical Research in Australia. He discusses how studying rare autoinflammatory diseases can reveal the genetic mutations and molecular pathways responsible for abnormal immune activation. He also explores how these discoveries are leading to more targeted treatments, the challenges of diagnosing rare inflammatory disorders, and how advances in genetic sequencing and stem cell models are helping identify new disease mechanisms. He also highlights the challenges of treating neuroinflammation and the importance of translating genetic discoveries into better patient care.
Featured Products and Resources:- Download the free cell separation e-book for everything you need to know about isolation techniques and protocols.
- Check out StainsFile for open access to protocols and resources to help you fix, prepare, and stain your specimens.
Pancreatic Tregs Promote Tissue Repair – Pancreatic regulatory T cells support tissue regeneration after injury but may also influence cancer treatment outcomes.
Dendritic Cells Drive Lymphoid Formation – Reprogrammed tumor cells induce tertiary lymphoid structures that strengthen anti-tumor immunity and may improve immunotherapy responses.
Basophils Regulate Treg Activity – Basophils limit early lung metastasis by suppressing regulatory T cells and enhancing anti-tumor CD8+ T cell responses in mice.
PAR4 Regulates Glioblastoma Immunity – Blocking platelet PAR4 signaling enhances anti-tumor T cell activity and improves survival in female glioblastoma mouse models.
Image courtesy of Dr. Seth Masters
Subscribe to our newsletter!Never miss updates about new episodes.
Subscribe